Willis覆膜支架治疗眼动脉段动脉瘤的单中心经验
该单中心研究纳入2015年1月至2017年8月在华西医院接受Willis覆膜支架治疗的26例眼动脉段动脉瘤患者,术后即刻24例完全闭塞、2例微量内漏,3至15个月血管造影随访全部完全闭塞,2例支架内狭窄,临床随访除1例术后10天发生蛛网膜下腔出血、左额叶出血及脑积水外无迟发性血栓栓塞、缺血或出血事件。作者认为Willis覆膜支架或可为复杂眼动脉段动脉瘤提供重建并保留颈内动脉的替代方案,并确认其安全性、有效性和中期耐久性。
要点
- 26例眼动脉段动脉瘤患者中,术后即刻24例完全闭塞、2例微量内漏。
- 3至15个月血管造影随访显示全部患者完全闭塞,2例出现支架内狭窄。
- 临床随访除1例术后10天发生蛛网膜下腔出血、左额叶出血及脑积水外,无迟发性血栓栓塞、缺血或出血事件。
核心结论
- 作者认为Willis覆膜支架或可为复杂眼动脉段动脉瘤提供通过重建并保留颈内动脉的替代解决方案。
- 作者认为该研究确认了Willis覆膜支架治疗复杂眼动脉段动脉瘤的安全性、有效性和中期耐久性。
研究设计与样本
- 单中心研究,纳入2015年1月至2017年8月在华西医院接受血管内技术治疗的眼动脉段动脉瘤患者162例中采用Willis覆膜支架治疗的26例。
- 26例患者共26个动脉瘤,平均年龄57.0岁(范围22至76岁)。
- 队列包括大或巨大动脉瘤20例、血泡样动脉瘤3例、假性动脉瘤3例;眼动脉型10个、颈内动脉型16个。
- 24例使用1枚支架,2例使用2枚支架。
主要发现
- 术后即刻血管造影显示24例完全闭塞,2例微量内漏。
- 1例完全闭塞患者出现造影剂外渗,术中经球囊压迫后该现象消失。
- 3至15个月血管造影随访显示全部患者完全闭塞,包括术后即刻血管造影时2例微量内漏患者。
- 2例患者出现支架内狭窄征象。
- 临床随访显示支架置入血管区域无迟发性血栓栓塞或缺血事件,除1例术后10天发生蛛网膜下腔出血、左额叶出血及脑积水外无患者发生出血。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The purpose of this study is to introduce our initial experience with the evaluation of the feasibility of using Willis covered stents (WCSs) in the treatment of complicated ophthalmic artery (OA) segment aneurysms. METHODS: Of the 162 patients with OA segment aneurysms treated by endovascular techniques in West China Hospital from January 2015 to August 2017, a total of 26 patients treated with WCSs were included in the study. RESULTS: Twenty-six patients with 26 aneurysms were included (mean age, 57.0 years; range, 22-76 years). The cohort had 20 patients with large or giant aneurysms, 3 patients with blood blister aneurysms, and 3 patients with pseudoaneurysms. Ten aneurysms were OA type, and 16 were internal carotid artery (ICA) type. Twenty-four patients were treated with 1 stent, and 2 patients were treated with 2 stents. Among the 26 patients, 2 patients had minimal endoleak, and 24 patients had complete occlusion after immediate postoperative angiography. One patient who had complete occlusion experienced contrast agent extravasation, and this phenomenon disappeared by balloon compression during the procedure. The 3- to 15-month angiographic follow-up showed that all patients experienced complete occlusion, including 2 patients with minimal endoleak during immediate postprocedural angiography. Two patient showed signs of in-stent stenosis. Clinical follow-up demonstrated that no delayed thromboembolic or ischemic events were recorded in the stent-grafted vascular region and no bleeding occurred in any of the patients (except 1 patient who experienced subarachnoid hemorrhage, left frontal lobe hemorrhage, and hydrocephalus 10 days after the procedure). CONCLUSIONS: WCSs may provide an alternative solution for treating complex OA segment aneurysms by reconstruction and preservation of the ICA. Our study also confirms the safety, efficacy, and midterm durability of WCSs for complex OA segment aneurysms.
引用
- Liu LX, Zhang CW, Lin S, et al. Application of the Willis Covered Stent in the Treatment of Ophthalmic Artery Segment Aneurysms: A Single-Center Experience. World Neurosurg. 2018. PMID: 30889778. doi:10.1016/j.wneu.2018.10.098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。